- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01523665
Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System
Evaluation of Blood Glucose Control in Intensive Care Patients Using the Space GlucoseControl System
Glucose metabolism is impaired in many critically ill patients and is often aggravated by parenteral feeding, infections and/or pre-existent diabetes.Therefore insulin infusion protocols, which are based on frequent bedside glucose monitoring, have been implemented on most critical care units. Despite extensive efforts of the intensive care unit staff difficulties were experienced in achieving efficient and safe glucose control. Several barriers to the implementation of glycemic control have been identified. Most importantly, there is concern about increased frequency of severe hypoglycemic episodes. To overcome these problems Space GlucoseControl was developed as a decision support system which helps to achieve safe and reliable blood glucose control in the desired ranges (4.4 - 6.1 mmol/l or 4.4 - 8.3 mmol/l).
The objective of this non-interventional study is to gain additional information on the performance of the Space GlucoseControl system for glycaemic control in ICU patients when used in routine clinical practice.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Copenhagen, Danmark
- Rigshospitalet Copenhagen
-
Vejle, Danmark
- Vejle Sygehus
-
-
-
-
-
Bury St Edmonds, Det Forenede Kongerige
- West Suffolk Hospital
-
Truro, Det Forenede Kongerige
- Royal Cornwall Hospital
-
-
-
-
-
Tartu, Estland
- Tartu University Hospital
-
-
-
-
-
Legnano, Italien
- Investigational Site
-
Siena, Italien
- Investigational Site
-
-
-
-
-
Wroclaw, Polen
- Wroclaw Medical University
-
-
-
-
-
Madrid, Spanien
- Hospital Sur,
-
-
-
-
-
Jönköping, Sverige
- Investigational Site
-
Stockholm, Sverige
- Investigational Site
-
Södertälje, Sverige
- Investigational Site
-
-
-
-
-
Hradec Kralove, Tjekkiet
- Investigational Site
-
Plzen, Tjekkiet
- Investigational Site
-
Prague, Tjekkiet
- Investigational sites
-
-
-
-
-
Augsburg, Tyskland
- Klinikum
-
Leipzig, Tyskland
- Universitätsklinikum Leipzig
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion:
- Intensive care patients who require blood glucose control by intravenous application of insulin
Exclusion:
- All contraindication of intravenous insulin therapy
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Blood glucose values: Percentage of time within the chosen glucose target range of 4.4 - 6.1 mmol/l or 4.4 - 8.3 mmol/l
Tidsramme: From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Frequency of hypoglycaemic episodes
Tidsramme: From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
Adherence to the advice of the Space GlucoseControl system
Tidsramme: From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
Blood glucose measurement interval
Tidsramme: From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
From start of treatment to the last glucose measurement under treatment, typically up to 14 days.
|
Samarbejdspartnere og efterforskere
Sponsor
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- HC-O-H-1102
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Intensive patienter
-
Norwegian University of Science and TechnologyRekruttering
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceRekrutteringÆldre patient (80 år eller ældre) indlagt på intensivFrankrig
-
Okan UniversityIkke rekrutterer endnuIntensiv afdeling erhvervet svaghed | Intensiv pleje, intuberet patient, tidlig mobilisering, mobilisering, respiratorisk mønsterKalkun
-
Bartın UnıversityZonguldak Ataturk State HospitalAfsluttetSøvn | Intensiv afdeling erhvervet svaghed | Patient ComplianceKalkun
-
Assistance Publique - Hôpitaux de ParisAfsluttetPatienter døde på intensiv afdeling (ICU)Frankrig
-
University Hospital, Clermont-FerrandUkendtPatient indlagt på Sygdomsinfektionsenhed | Patient indlagt på Intensiv Reanimation Unit | Patient indlagt på internmedicinsk afdelingFrankrig
-
University Hospital, Clermont-FerrandAfsluttetVentileret patient på intensiv | Håndtering af det eksspiratoriske ende-eksspiratoriske tryk (PEEP) og kropspositionFrankrig
-
Seoul National University HospitalRekrutteringIntensiv afdeling erhvervet svaghed | Kritisk syg patientKorea, Republikken
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekrutteringPatientrapporterede resultatmål | CAR T-celleterapiSchweiz
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T Terapi KomplikationerItalien